International Journal of Environmental Research and Public Health,
Journal Year:
2024,
Volume and Issue:
21(8), P. 986 - 986
Published: July 27, 2024
Given
diversified
cannabis
products,
we
examined
associations
between
consumption
methods
and
risk
perception
of
smoking
1–2
times
a
week.
Using
the
2022
U.S.
National
Survey
on
Drug
Use
Health
data
(N
=
12,796
past-year
adult
users;
M
6127
F
6669),
used
multinomial
binary
logistic
regression
models.
Smoking
was
most
prevalent
method,
followed
by
eating/drinking,
vaping,
dabbing.
One-half
users
reported
no
perceived
week,
37.5%
slight
risk,
9.2%
moderate
2.9%
great
risk.
Those
with
or
had
lower
likelihood
using
4+
(e.g.,
RRR
0.40,
95%
CI
0.20,
0.77
for
perception).
Any
associated
higher
odds
edibles/drinks
only
aOR
2.81,
1.43,
5.54
Along
medical
use
CUD,
sociodemographic
factors,
mental
illness,
other
substance
were
also
significant
correlates
methods.
Understanding
varying
perceptions
different
is
needed
harm
reduction
initiatives.
More
research
particularly
dabs/concentrates,
to
better
understand
potential
risks
them.
Deutsches Ärzteblatt international,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 16, 2024
The
federal
government
of
Germany
is
planning
to
liberalize
the
recreational
cannabis
market
for
adults.
We
aimed
collect
key
baseline
data
on
frequency
use,
routes
administration,
and
co-use
inhaled
nicotine
or
tobacco
products
in
population.
Neuropsychopharmacology,
Journal Year:
2024,
Volume and Issue:
49(9), P. 1425 - 1436
Published: March 25, 2024
Cannabidiol
(CBD)
is
widely
used
and
believed
to
be
non-intoxicating,
lacking
acute
performance
effects
(e.g.,
non-impairing).
However,
a
synthesis
of
data
has
not
evaluated
this.
This
meta-analysis
synthesized
from
controlled
human
laboratory
studies
that
if
CBD
use
impairs
performance.
Performance
on
objective
subjective
measures
cognitive
psychomotor
function
were
as
markers
for
potential
changes
impairment.
Studies
identified
through
systematic
database
searches.
Adult
clinical
trials
measuring
(within
0-8
h
administration)
included.
The
primary
outcome
was
the
peak
mean
difference
in
between
placebo.
A
secondary
analysis
utilizing
delta-9-tetrahydrocannabinol
(Δ9-THC)
positive
control
comparison
completed.
Pooled
Hedges'
g
estimates
calculated
using
robust
variance
estimation
(RVE)
meta-regression.
omnibus
RVE
indicated
statistically
significant,
but
small
effect
size
(Hedge's
<
0.2)
impaired
following
consumption
compared
placebo
(N
=
16
trials,
0.122,
95%
CI:
0.023-0.221,
p
0.019).
Measure
type
significant
moderator
with
larger
differences
when
measures,
specifically
self-reported
sedation,
versus
tasks
(Hedges'
Cannabis and Cannabinoid Research,
Journal Year:
2024,
Volume and Issue:
9(4), P. e1184 - e1196
Published: Jan. 8, 2024
Cannabis
is
the
most
used
illicit
drug
in
United
States.
With
many
states
passing
legislation
to
permit
its
recreational
use,
there
concern
that
cannabis
use
among
adolescents
could
increase
dramatically
coming
years.
Historically,
it
has
been
difficult
model
real-world
investigate
causal
relationship
between
adolescence
and
behavioral
neurobiological
effects
adulthood.
Substance Abuse Treatment Prevention and Policy,
Journal Year:
2024,
Volume and Issue:
19(1)
Published: June 17, 2024
Abstract
Background
Canada
legalized
recreational
cannabis
in
2018,
and
one
of
the
primary
objectives
Cannabis
Act
was
to
protect
youth
by
reducing
their
access
providing
public
education.
has
highest
prevalence
use
worldwide,
particularly
among
young
adults
under
age
25.
is
linked
with
many
adverse
effects
for
including
psychosis,
anxiety,
depression,
respiratory
distress,
cannabinoid
hyperemesis
syndrome,
impaired
cognitive
performance.
Despite
high
evolution
policies
globally,
significant
knowledge
research
gaps
remain
regarding
adult
use.
The
aim
this
scoping
review
map
extent,
nature,
range
evidence
available
on
since
its
legalization,
order
strengthen
policies,
services,
treatments,
training,
education
strategies.
Methods
Using
a
framework
developed
Arksey
O’Malley,
along
PRISMA-ScR
guidelines,
we
conducted
rigorous
search
five
academic
databases:
MEDLINE,
Embase,
APA
PsycINFO,
CINAHL
Web
Science
Core
Collection.
We
included
empirical
studies
that
collected
data
after
legalization
(October
2018)
focused
or
<
30.
Two
reviewers
independently
screened
articles
two
stages
extracted
relevant
information
from
meeting
inclusion
criteria.
Results
Of
47
our
criteria,
92%
used
quantitative
methods,
6%
were
qualitative,
2%
mixed-methods
approach.
Over
two-thirds
(68%)
secondary
data.
These
categorized
into
six
focus
areas:
(1)
prevalence,
patterns,
trends,
(2)
cannabis-related
injuries
emergency
department
(ED)
visits,
(3)
rates
patterns
during
pandemic,
(4)
perceptions
use,
(5)
prevention
tools,
(6)
offenses.
Key
findings
reviewed
include
an
increase
18-24-year-olds
post-legalization,
mixed
results
18.
ED
visits
intentional
unintentional
have
increased
children
teens.
Perception
show
mix
concern
normalization
Though
limited,
are
promising
raising
awareness.
A
decline
offenses
noted
study.
highlights
several
gaps,
need
more
qualitative
data,
disaggregation
demographic
intervention
research,
comprehensive
physical
mental
health
impacts
adults.
Conclusion
Maintaining
approach
critical,
This
involves
implementing
strategies
minimize
harms,
enhancing
education,
minimizing
commercialization,
cannabis,
promoting
guidelines
lower-risk
harm
reduction
strategies,
increasing
training
healthcare
providers.
Assessment,
Journal Year:
2024,
Volume and Issue:
32(1), P. 77 - 89
Published: March 21, 2024
Given
the
popularity
and
ease
of
single-item
craving
assessments,
we
developed
a
multi-item
measure
compared
it
to
common
assessments
in
an
ecological
momentary
assessment
(EMA)
context.
Two
weeks
EMA
data
were
collected
from
48
emerging
adults
(56.25%
female,
85.42%
White)
who
frequently
used
cannabis.
Eight
items
administered,
multilevel
factor
analyses
identify
best
fitting
model.
The
resulting
scale’s
factors
represented
purposefulness/general
desire
emotionality/negative
affect
craving.
Convergent
validity
was
examined
using
measures
craving,
cannabis
use
disorder
symptoms,
frequency
use,
cue
reactivity,
negative
affect,
impulsivity.
scale
associated
with
cue-reactivity
impulsivity,
subfactors
existing
measures.
For
researchers
interested
single
item
capture
one
performed
particularly
well.
However,
new
may
provide
more
nuanced
mechanisms
underlying
The International Journal of Neuropsychopharmacology,
Journal Year:
2023,
Volume and Issue:
26(11), P. 773 - 783
Published: Sept. 16, 2023
Cannabis
edibles
are
an
increasingly
popular
form
of
cannabis
consumption.
Oral
consumption
has
distinct
physiological
and
behavioral
effects
compared
with
injection
or
inhalation.
An
animal
model
is
needed
to
understand
the
pharmacokinetics
oral
in
rodents
as
a
for
human
edible
use.Adult
male
female
C57BL/6
mice
received
single
dose
commercially
available
oil
(5
mg/kg
Δ⁹-tetrahydrocannabinol
[THC])
by
gavage.
At
0.5,
1,
2,
3,
6
hours
post
exposure,
plasma,
hippocampus,
adipose
tissue
were
collected
THC,
11-OH-THC,
THC-COOH
measures.We
report
delayed
time
peak
THC
11-OH-THC
concentrations
brain,
tissue,
which
consistent
studies.
We
also
found
sex
differences
tetrad:
(1)
had
hypothermic
effect
consumption,
was
not
present
males;
(2)
females
stronger
catalepsy
than
(3)
males
less
mobile
following
whereas
showed
no
difference
locomotion
but
anxiogenic
at
3
exposure;
(4)
displayed
longer-lasting
antinociceptive
cannabis.Oral
translationally
relevant
administration
that
produces
similar
vaping
thus
should
be
considered
viable
approach
examining
moving
forward.
Furthermore,
given
strong
metabolism
cannabis,
these
factors
carefully
when
designing
studies
on
cannabis.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 11, 2025
Abstract
The
legalization
of
cannabis
in
several
states
across
the
US
has
increased
need
to
better
understand
its
effects
on
body,
brain,
and
behavior,
particularly
different
populations.
Rodent
models
are
valuable
this
respect
because
they
provide
precise
control
over
external
variables.
Previous
rodent
studies
have
found
age
sex
differences
response
injected
Δ
9
-tetrahydrocannabinol
(THC),
major
psychoactive
component
cannabis.
However,
route
administration
does
not
mimic
most
common
way
humans
consume
cannabis,
i.e.
through
inhalation.
Here,
we
sought
address
gap
by
investigating
pharmacokinetics
acute
behavioral
vaporized
extract
mice.
Adolescent
(postnatal
day
[P]
35-50)
adult
(≥
P70)
mice
both
sexes
received
noncontingent
exposure
0
mg/ml,
150
or
300
mg/ml
diluted
either
80%
propylene
glycol/20%
vegetable
glycerol
(PG/VG)
100%
polyethylene
glycol
400
(PEG).
Immediately
after
exposure,
body
temperature,
hot
plate
withdrawal
latency,
locomotion
were
assessed.
Blood
was
collected
at
0,
30,
60
min
vapor
plasma
THC
metabolites
analyzed.
Measured
levels
higher
vapor-exposed
solutions
themselves
when
PEG
solvent
compared
PG/VG.
Vaporized
(dissolved
PEG)
highest
dose
tested
induced
hypothermic,
antinociceptive,
locomotor-suppressing
all
groups
We
a
dose-dependent
difference
locomotion,
indicating
that
adolescents
less
sensitive
which
may
be
related
achieved.
Although
no
significant
there
female
metabolize
more
slowly
than
male
Taken
together,
current
findings
add
growing
number
implementing
cannabinoid
delivery
approaches
revealing
as
superior
for
involving
extract.
Addiction,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 21, 2025
Abstract
Aims
Some
cannabis
consumption
methods
(e.g.
smoking,
vaping,
dabbing)
are
associated
with
more
harms
than
others
sublingual,
transdermal).
We
aimed
to
examine
differences
in
prevalence
of
by
people
medically
recommended‐only
vs.
nonmedical‐only
use.
Design
and
setting
Cross‐sectional,
US
nationally
representative
data
from
the
2022
National
Survey
on
Drug
Use
Health
(NSDUH).
Participants
14
271
NSDUH
participants
aged
≥12
past‐year
Measurements
asked
respondents
use
about
their
[i.e.
eating
or
drinking,
dabbing
(consuming
a
concentrated
form
dab
rig/pen),
oral/sublingual,
transdermal
taking
pills]
if
healthcare
professionals
recommended
any
If
‘no’,
were
classified
as
having
‘
use’.
‘yes’,
they
all
was
and,
so,
use’;
otherwise,
medical
nonmedical
Findings
Among
reporting
use,
10.7%
[95%
confidence
interval
(CI)
=
9.7%–11.7%]
reported
83.0%
(95%
CI
81.7%–84.3%)
Smoking
predominant
method
for
(79.2%,
95%
77.7%–80.7%)
(73.7%,
68.8%–78.2%).
Vaping
(45.6%,
40.9%–50.4%)
eating/drinking
(45.7%,
40.7%–50.7%)
similar
among
1.3
times
higher
[adjusted
ratio
(APR)
1.3,
1.2–1.4]
(38.3%,
32.7%–44.3%).
Dabbing
1.5
(APR
1.5,
1.3–1.7)
[24.4%
20.5%–28.8%)
vs
16.4%
15.3%–17.7%)].
Higher
oral/sublingual
Conclusions
US,
three‐fourths
smoking
almost
half
vaping
cannabis.
Cannabis
1.3–1.5
higher,
respectively,
International Journal of Environmental Research and Public Health,
Journal Year:
2025,
Volume and Issue:
22(4), P. 495 - 495
Published: March 26, 2025
Cannabis
use
among
young
adults
in
the
U.S.
has
nearly
doubled
recent
years,
driven
by
diverse
methods
of
consumption
and
evolving
cannabis
legalization.
Multi-modal
is
an
emerging
public
health
issue
that
remains
underexplored.
This
study
examines
prevalence,
patterns,
predictors
multi-modal
use,
defined
as
two
or
more
administration
(e.g.,
smoking,
vaping,
edibles,
dabbing,
other
forms)
past
month,
aged
18–34
years.
Data
from
2022–2023
Behavioral
Risk
Factor
Surveillance
System
(BRFSS)
across
23
states
(n
=
7635;
weighted
n
7,482,134)
show
57%
reporting
current
engaged
with
dual-
triple-mode
being
most
common.
Factors
associated
higher
odds
include
sexual
minority
status,
poor
physical
health,
frequent
co-use
electronic
cigarettes
alcohol.
Recreational
legalization
(RCL)
significantly
linked
to
use.
These
findings
underscore
interplay
between
individual
risk
factors
policy
environments
shaping
behaviors.
To
mitigate
potential
harms,
targeted
prevention
strategies
should
prioritize
at
for
addressing
both
personal
policy-related
influencing